World Financial News Network Continues to Recommend Micro Laboratories

Share Article

Dr. Joseph de Beauchamp of World Financial News Network started coverage and gives favorable analysis to Micro Laboratories as a company that helps people with better absorption for vitamins and minerals.

WFNN's consistently outperforms established industry benchmark indicators. Based on in-depth research and analysis, their analysts recommend securities worldwide showing the highest probability for stock price appreciation. With constant vigil, WFNN looks for economic opportunities in the private and public company sectors.

Dr. Joseph de Beauchamp, WFNN's Chief Independent Analyst, said, Sublingual delivery through the line of MicroSpray(R) vitamins, minerals and nutritional supplements produced by Micro Laboratories, Inc., offers maximum absorption, ease of use, a pleasant taste, and is the most convenient, effective and efficient method of administering vitamins and nutrients. Additionally, the product shows mass appeal to key markets worldwide: children, seniors, nutritionally deficient, gastro-intestinally challenged, and the mainstream population who need and desire a better way to take their vitamins. We see the stock moving up to $1.00 short term and then on to $5.00 per share in several years. The company looks to show positive earnings in the next twelve months. "

For brief information of this new, dynamic company, examine: http://wfnn.info displaying in the search engine section.

About WFNN: World Financial News Network provides a unique blend of data, timely information and today's technologies to assist with up-to-the-minute investment and economic values on markets and investments around the world.

About Micro Laboratories: Micro Laboratories operates to produce, market and distribute a line of oral Spray vitamins, trade name "Micro SprayT". Micro intends to produce, market and distribute an additional product line of, minerals, herbs and other oral absorption products in the United States and the international market. Therefore, Micro's financial viability will depend almost exclusively on Micro's ability to generate revenues from its operation, and the production of the above product lines. Micro will not have the benefit of reducing its financial risks by relying on revenues derived from other operations.

Todd David, CEO

Micro Laboratories, Inc. (OTC: MLAR)

29 Lakeside Dr., PO Box 19296

Johnston, RI 02919-0296

Phone: 401-949-3562

Toddski17@yahoo.com

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joseph De Beauchamp
WFNN
206-343-3912
Email >
Visit website